Maelstrom Research Staging | POPCORN_COVID19_MISC_Control_Second_followup

POPCORN_COVID19_MISC_Control_Second_followup_2months

Networks -

Variables -

Associated study POPCORN-COVID-19 Contingency Table

Population

POPCORN-COVID-19 - MIS-C - Control

The population is composed of children under 18 years of age who are pediatric ED patients or inpatient ward units with acute non-febrile or mild febrile illness, accidental injury, or outpatients requiring bloodwork for other reasons and who have a recent history of COVID-19 vaccination (past 30 days) or with clinical criteria consistent with MIS-C cases but, upon assessment by a physician, did not receive the diagnosis.

Selection Criteria

Maximum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Paricipants are included in the the study if they; * Presented or admitted to a participating pediatric ED, inpatient ward, or PICU * Fever in last 24 hours * Diagnostic bloodwork for MIS-C was ordered or expected to be ordered based on assessment by triage or admitting teams however, an alternate diagnosis was determined, or investigations were normal. * Another known cause for the child’s presentation determined prior to blood draw

Other Criteria

Supplementary Information about selection criteria

Participants consented to the biobank only as a biobank control.

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Paricipants are recruited across 16 academic pediatric institutions which are BC Children’s Hospital (Vancouver), Stollery Children’s Hospital (Edmonton), Alberta Children’s Hospital (Calgary), Jim Pattison Children’s Hospital (Saskatoon), The Children’s Hospital of Winnipeg (Winnipeg), McMaster Children’s Hospital (Hamilton), The Hospital for Sick Children (Toronto), Kingston Health Sciences Centre (Kingston), Children’s Hospital of Eastern Ontario (Ottawa), Children's Hospital London Health Sciences Centre (London), Montreal Children’s Hospital (Montreal), CHU Sainte-Justine (Montreal), CHU de Sherbrooke (Sherbrooke), CHU de Quebec l‘Université de Laval (Quebec City), Janeway Children’s Health and Rehabilitation Centre (St. John’s), and IWK Health Centre (Halifax).

Number of Participants

Number of Participants: 300
Number of Participants with Biological Samples: 200

More info

Data Collection Event

POPCORN-COVID-19 - MIS-C Control - Second follow-up (2 months)

Information on patient status, healthcare encounters (visits and stays at the hospital/ED), SARS-CoV-2 infections (symptoms, history, testing, exposure) and vaccinations (dates, vaccine manufacturer, number of doses), chronic symptoms (respiratory, neurological, psychological), medications, quality of life (Pediatric Quality of Life Inventory) and disability (Functional Status Scale Survey) is collected. Information is also collected about new myo/pericarditis and multisystem inflammatory syndrome events and adverse events following immunization for a subset of participants. Blood samples are collected for a subset of participants.

More info

Collected Dataset / POPCORN_COVID19_MISC_Control_Second_followup_2months

POPCORN_COVID19_MISC_Control_Second_followup_2months

Population

POPCORN-COVID-19 - MIS-C - Control

Data Collection Event

POPCORN-COVID-19 - MIS-C Control - Second follow-up (2 months)

Files

Variables Classifications